Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. - Concepedia

Concepedia

Publication | Closed Access

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.

221

Citations

25

References

1994

Year

Kenneth J. Pienta, Bruce G. Redman, Mohamad A. Hussain, Glenn Cummings, Peggy S. Esper, C Appel, Lawrence E. Flaherty

Journal of Clinical Oncology

Abstract

We conclude that the combination of estramustine and VP-16 is an active oral regimen in hormone-refractory prostate cancer.

References

	Year	Citations

Page 1